Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Walgreen

This article was originally published in The Tan Sheet

Executive Summary

Walgreen: Drug store chain reports sales up 14.1% to $3.5 bil. in the first quarter ended Nov. 30. As a result of an accounting change in which the company took a 5 [cents] per share charge against earnings, net earnings fell 18.7% to $61 mil. Excluding the effect of the new accounting interpretation, earnings increased 16% to $87 mil. The firm opened 58 new Walgreens during the quarter, of which 20 were relocations to "more convenient, freestanding locations," the company said. The firm expects to exceed its targeted 280 store openings in fiscal 1998 and, "by 1999, we'll open a store a day," it notes...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087952

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel